More importantly, we provided a proof of concept that proinflammatory COX-1 signaling in a RP animal model could be suppressed pharmacologically, suggesting a potential path to a practical clinical application from our data. This evidence concerns the gene PTGS1 and retinitis pigmentosa 1.